Skip to main content

Reduction of testosterone levels in Schistosoma haematobium- or Schistosoma mansoni-infected men: a cross-sectional study in two schistosomiasis-endemic areas of the Adamawa region of Cameroon



The incidence of schistosomiasis‐induced male reproductive dysfunction and infertility is probably underestimated compared to female genital schistosomiasis. This study aimed to investigate the impact of Schistosoma haematobium or S. mansoni infection on the reproductive function of men of reproductive age in Tibati and Wouldé, two endemic schistosomiasis areas in the Adamawa region of Cameroon.


A total of 89 men of reproductive age (range 14–56 years) from two localities were enrolled in the study, with 51 in Tibati and 38 in Wouldé. Each participant was submitted to a questionnaire to document data on sociodemographic and stream contact behaviors. A medical examination was performed to measure the testes’ circumference and evaluate genital tract pathologies. Stool and urine samples were collected and screened for the presence of S. haematobium or S. mansoni ova. Blood serum was used to assess the levels of transaminases and testosterone.


Schistosoma haematobium was present only in Tibati, with a prevalence of 31.37%. The S. mansoni prevalence was 3.92% at Tibati and 44.71% at Wouldé. The intensity of infection was 22.12 ± 9.57 eggs/10 mL for S. haematobium and 128.10 ± 3.76 epg for S. mansoni. Serum transaminase activity and the mean testicular circumference of Schistosoma-positive individuals were close to Schistosoma-negative individuals. However, the testes size was more prominent in S. mansoni-positive individuals than in S. haematobium-positive individuals (P < 0.05). The serum testosterone levels of S. haematobium- and S. mansoni-positive men were significantly reduced by 56.07% (P < 0.001) and 51.94% (P < 0.01), respectively, in comparison to those of Schistosoma-negative men. A significant and negative correlation was established between schistosomiasis and the low serum testosterone level. Male genital tract pathologies such as scrotal abnormalities, varicocele, nodular epididymis, inguinal hernia, and hydrocele were recorded in both Schistosoma-positive and Schistosoma-negative men. However, no significant link was established between schistosomiasis infection and these pathologies.


These results demonstrated that infection with S. haematobium or S. mansoni is associated with low production of the reproductive hormone testosterone and may be a significant cause of male infertility.

Peer Review reports


Schistosomiasis is an acute and chronic disease caused by Schistosoma blood flukes. In Cameroon, three species of human schistosomes occur S. haematobium, S. mansoni, and S. guineensis. People are infected while exposed to infested water during routine agricultural, domestic, occupational, and recreational activities. In 2016, the global burden of schistosomiasis was estimated at 2.50 million disability-adjusted life years (DALYs). Schistosomiasis remains a major public health problem, with at least 229 million people worldwide, and almost 90% of them lived in sub-Saharan Africa, requiring preventive chemotherapy in 2018 [1]. In Cameroon, it was estimated that 47% of the population (9,484,894 million) was at risk of schistosomiasis infection and needed preventive treatment in 2010 [2]. The country’s three northern regions, the Far North, North, and Adamawa, are the most affected. Some health districts in the South-West, Littoral, West, and Centre regions showed a high prevalence of infection. Epidemiological data collected in some schools of the Adamawa region in 2006 revealed that 14.2% of the children were infected with at least one schistosome species [3]. The strategy of choice to control schistosomiasis remains preventive chemotherapy with praziquantel. School-aged children are the primary target of these therapeutic interventions since they are the most vulnerable and most affected by the infection [4]. In Cameroon, fishermen, farmers, and irrigation workers are also high-risk groups for schistosome infection, but they are not enrolled in deworming campaigns with praziquantel [3, 5]. Schistosoma-positive adults generally suffer from chronic schistosomiasis with severe consequences such as liver fibrosis, portal hypertension, ascites, calcification of the bladder, kidney failure, and genital dysfunction [2]. Genital schistosomiasis occurs when Schistosoma circulating eggs invade the reproductive tissues of the host. It has been associated with female and male reproductive health problems such as ectopic pregnancies, abortion, low sperm count, coitus pain, vaginal bleeding, genital organ enlargement and infertility [6,7,8]. Female genital schistosomiasis (FGS) is well documented, and its prevalence is considerable in S. haematobium endemic areas (33 to 75%) [6, 9,10,11,12]. In contrast to FGS, male genital schistosomiasis (MGS) is underreported, and its burden is underestimated. S. haematobium and S. mansoni are the two species involved in MGS. The main findings reported in patients who have traveled or lived in schistosomiasis endemic areas are swelling of the scrotum and other genital organs, dilatation, and calcification of the prostate and seminal vesicles, haemospermia, hydrocele, changes in semen/ejaculate, infertility, and urethral discharge [7, 13]. Case reports have mentioned the presence of S. haematobium or S. mansoni eggs in male genital organs and semen of some young and adult patients [14,15,16,17,18,19,20,21,22,23,24]. Variation in the levels of sex hormones was also reported in some male patients with S. haematobium and/or S. mansoni [25,26,27,28,29].

In Cameroon, investigations on the association of schistosomiasis and the male reproductive tract have drawn no attention from researchers. To the best of our knowledge, this is the first report on male genital schistosomiasis in Cameroon. This study aimed to investigate the impact of infection with S. haematobium or S. mansoni on the reproductive tract of men of reproductive age in Tibati and Wouldé, two endemic schistosomiasis areas in the Adamawa region of Cameroon.


Study area

Cameroon is divided into ten regions at the first level, 58 divisions at the second level, and 360 subdistricts at the third level. According to the United Nations, the population of Cameroon was estimated to be 25,876,380 inhabitants in 2019, with 1,200,970 inhabitants in the Adamawa region [30]. The Adamawa region is divided into five divisions: Vina, Mbéré, Mayo Banyo, Djerem and Faro et Déo. Tibati, the capital of the “Djerem” division, is situated between 6° 47′ N and 12° 63′ E. It is a semi-urban area with a population density of 7 inhabitants/km2. Located in the “Pagneré” neighborhood, Lake Pagneré is the largest in the city. Trading, fishing, and fish mongering are the main activities in Tibati. Wouldé is a village in the Mayo-Baléo subdistrict in the “Faro et Déo” division. It is situated between 7° 43′ N and 12° 47′ E and is surrounded by volcanic hills. At the entrance of this rural area flows the Wouldé River with its thermal source. The population density is 6.6 inhabitants/km2, and the major occupations in this community are farming, livestock, and trading. The vegetation of the Adamawa region falls within the rainforest-savannah mosaic, and the climate is a sudano-guinean type with an annual rainfall of 1500 mm. Schistosomiasis transmission presumably occurs in lakes, rivers, ponds, and marshy fields. Fulbe and Kutin ethnic groups are predominant in Tibati and Wouldé, and they are mainly Muslims. Therefore, we localized Tibati and Wouldé on the study area map conceived and realized by our research team (Fig. 1). Tibati and Wouldé (Adamawa region) belong to the S. haematobium and S. mansoni transmission zones. In addition, S. guineensis is found in a few localities of the Far North, North, Centre, South, Littoral, and South West [3].

Fig. 1
figure 1

Study area: Tibati and Wouldé

Ethical considerations

This study was approved by the National Ethics Committee of Cameroon (No. 072/CNE/DNM/08). Surveys were conducted in the communities with the approval of administrative authorities. The study’s objectives were explained to the populations, and each participant signed informed consent. When a participant was under 16 years old, written informed consent was obtained from a parent or guardian. The results were sent to each participant at the end of the study. Each Schistosoma-positive person was treated with praziquantel 600 mg/mL at the dose of 40 mg/kg per day orally in two divided doses for one day.

Study design

The people involved in the study were all male volunteers of reproductive age who were residents of Lake Pagneré in Tibati and of the “Chefferie” neighborhood in Wouldé. In this study, we included non-adult men under 18 years old (14 to 17 years) when they were sexually active and were in couple with their girlfriends. Thoughtfully ill individuals showing incapacitation were not included in the study. A questionnaire was administered to each participant for personal information, fertility status, and history of sexually transmissible infections. In addition, participants underwent physical examination by a male medical practitioner to assess palpation genital tract pathologies such as varicocele, hydrocele, nodular epididymis, scrotal abnormalities, and inguinal hernia. The circumference of the two testes was also measured. Initially planned in the study, sperm collection to search for the presence of schistosome ova and conduct semen analysis was not carried out because of cultural considerations (masturbation being a taboo in those localities). Instead, urine and stool samples and blood were collected from each participant for parasitological and biochemical analyses.

Samples collection

Urine and stool samples were collected in 60 mL plastic screw-cap vials, and blood was collected in 5 mL dry tubes between 10.00 a.m. and 2.00 p.m. The samples were transported to the laboratory of the Divisional Hospital of Tibati or the Health district of Tignère for processing. In the laboratory, we determined hematuria in urine samples by naked eyes. We concluded to visible hematuria when blood was visible in the urine, coloring it pink, red, or dark brown. After that, each urine sample was agitated to ensure adequate dispersal of eggs, and 10 mL of urine was filtered through a Nucleopore® filter. The filters were examined by microscopy for the presence of schistosome eggs. Stool samples were examined by a single thick smear technique using a 41.7 mg Kato-Katz template. The number of eggs for each schistosome species was counted. The infection intensity was calculated and expressed as eggs per gram of feces (epg) for S. mansoni or eggs per 10 ml of urine (eggs/10 ml) for S. haematobium. Serum obtained from blood samples after coating was kept at − 20 °C and transported to the laboratory in an icebox for the assay.

Evaluation of the level of transaminases

Serum activities of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were evaluated by colorimetric methods using Commercial Fortress kits (Fortress Diagnostics, UK) according to the protocol given by the manufacturer. Absorbances were read against the blank at 505 nm. The ALT and AST activities were determined from their respective standard curves with a lower limit of detection of 0.00 UI/L for ALT and AST and an upper limit of detection of 97 UI/L for ALT and 89 UI/L for AST.

Testosterone assay

Concentrations of serum testosterone were evaluated by an enzyme immunoassay using the Human Testosterone ELISA kit (Invitrogen). A volume of 50 µL of standards and samples were dispensed in microtiter plates. After adding 100 µL of testosterone—HRP conjugate (testosterone labeled with horseradish peroxidase), plates were incubated for 60 min at room temperature. The competitive reaction was stopped by washing with wash buffer. Next, a chromogenic solution of 3-3′, 5-5′ tetramethylbenzidine (100 µL) was added to each well, and after incubation for 30 min at room temperature, 100 µL of the stop reagent (HCl 2 N) was added. Absorbance was read at 450 nm, and testosterone concentrations were determined from the standard curve with lower and upper limits of detection of 0.00 and 37.40 ng/mL, respectively.

Data analysis

The data for this study were entered into Excel and exported to R version 3.5.0 software for statistical analysis. In univariate analysis, central tendency and dispersion measures were reported for quantitative variables, while the frequencies and percentages were written for the modalities of qualitative variables. In bivariate analysis, frequencies and percentages were determined for Schistosoma-positive (SCH-positive) and Schistosoma-negative (SCH-negative) subjects, respectively, to evaluate its prevalence across groups of other qualitative variables. Equality of prevalence rates was tested using Pearson’s chi-squared test for equality of proportions. Differences in distributions for quantitative variables between SCH-positive and SCH-negative subjects were tested using the Kolmogorov–Smirnov test. Univariate logistic regression models were used to identify factors affected by Schistosoma infection. For the quantitative results of biochemical parameters, data were analysed using GraphPrism 8.0.1 by one-way analysis of variance (ANOVA), and differences between groups were assessed using the Tukey multiple comparison post-test. In all, the level of significance was set at 5%. The intensity of individual infection for S. mansoni (light: 1–99 epg; moderate: 100–399 epg; and heavy ≥ 400 epg) and S. haematobium (light: < 50 eggs/10 mL and heavy: ≥ 50 eggs/10 mL) was classified according to the WHO guidelines [31].


Sociodemographic characteristics of the participants

A total of 89 men of reproductive age (range 14–56 years) were enrolled in this study, with 51 in Tibati and 38 in Wouldé. The mean age of the population was 32.21 ± 1.16 years. Regarding the marital status of the participants, 53 (58.43%) were married, 32 (35.96%) were single with girlfriends, 4 (4.49%) were divorced, and 1 (1.12%) was widowed. The results revealed that 49.44% of the population was permanently in contact with schistosomiasis transmission sites (STS). Considering the study population per locality, 76.32% of the participants in Wouldé and 29.41% in Tibati were exposed to STS. (Table 1).

Table 1 Sociodemographic characteristics of the population of Tibati and Wouldé

Prevalence and intensity of infection

Table 2 summarizes the prevalence and intensity of S. haematobium and S. mansoni infection in the male of reproductive age involved in this study. S. haematobium was the most prevalent species in Tibati, with 31.37%, while the prevalence of S. mansoni was 3.92%. In Wouldé, S. haematobium was absent among the study population, and the prevalence of S. mansoni was 44.74%. The egg count for urogenital schistosomiasis ranged from 2 to 2620 eggs/10 mL and from 24 to 1224 epg for intestinal schistosomiasis. The geometric mean infection intensity was 22.12 ± 9.57 eggs/10 mL for S. haematobium and 128.10 ± 3.76 epg for S. mansoni. According to the degree of intensity of infection, 47.37% of S. mansoni-positive men presented light-intensity infection, 31.58% moderate-intensity infection, and 21.05% heavy-intensity infection. Light-intensity infection with S. haematobium represented 68.75%, while heavy-intensity infection was 31.25%. Visible hematuria was present in 80% of the men presenting S. haematobium heavy-intensity infection (Fig. 2).

Table 2 Prevalence and intensity of Schistosoma infection in the male adult population of Tibati and Wouldé
Fig. 2
figure 2

Degree of Schistosoma infection intensity in the adult male population of Tibati and Wouldé. Light-infection intensity: 1–99 epg; moderate-infection intensity: 100–399 epg; and heavy-infection intensity ≥ 400 epg for S. mansoni and for S. haematobium, light-infection intensity: < 50 eggs/10 mL and heavy-infection intensity: ≥ 50 eggs/10 mL

Serum activity of transaminases

The serum activity of transaminases was evaluated in the study population. The alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities of S. haematobium and S. mansoni-positive men were close to SCH-negative men. There was thus no significant difference in the serum activity of transaminases between SCH-positive men and SCH-negative men (Table 3).

Table 3 Transaminases activities of Schistosoma haematobium and Schistosoma mansoni-positive individuals of Tibati and Wouldé

Testicular size and serum level of testosterone

The mean testicular circumference of SCH-negative men was 9.26 ± 0.38 cm, and that of S. haematobium- or S. mansoni-positive men was 8.28 ± 0.49 cm and 10.71 ± 0.62 cm, respectively. These results revealed no significant difference between SCH-positive individuals and SCH-negative individuals. However, the testicular circumference of S. mansoni-positive men was higher than that of S. haematobium-positive men (P < 0.05) (Fig. 3a).

Fig. 3
figure 3

Mean testes circumferences (A) and serum testosterone levels (B) in Schistosoma haematobium- and Schistosoma mansoni-positive men in Tibati and Wouldé. Data are expressed as mean ± SEM. ANOVA followed by Tukey’s multiple comparison post hoc test was used for statistical analysis. αP < 0.05: values are significantly different from those of S. haematobium-positive men. **P < 0.01, ***P < 0.001: values are significantly different from those of SCH-negative men

The serum concentrations of testosterone were 3.40 ± 0.48 ng/mL and 3.72 ± 0.58 ng/mL for S. haematobium- and S. mansoni-positive men, respectively, versus 7.74 ± 1.07 ng/mL for SCH-negative men. In comparison to the SCH-negative group, Schistosoma infection induced a significant reduction in the serum level of testosterone by 56.07% in the S. haematobium-positive group (P < 0.001) and by 51.94% in the S. mansoni-positive group (P < 0.01) (Fig. 3b). A strong correlation was observed between Schistosoma infection and the serum testosterone level in the study population. The Spearman’s rho correlation coefficients were − 0.54 (P = 0.0101) and − 0.56 (P = 0.0006) for the groups of S. haematobium- and S. mansoni-positive men, respectively (Fig. 4).

Fig. 4
figure 4

Correlation curves between Schistosoma haematobium (A) or Schistosoma mansoni (B) intensity of infection and serum testosterone levels

Prevalence of genital tract pathologies

Table 4 shows the prevalence of genital tract pathologies in SCH-negative and SCH-positive men. Physical examination of the study population revealed that some men positive to S. haematobium or S. mansoni presented one or two of the following pathologies: varicocele, hydrocele, nodular epididymis, scrotal abnormalities, and inguinal hernia. Scrotal abnormalities were predominant with 25.00% and 52.63% of the cases in S. haematobium- and S. mansoni- positive men, respectively, versus 40.74% of patients in SCH-negative men. Varicocele and nodular epididymis were also detected in approximately 20.00% of SCH-positive men. These pathologies were also present in SCH-negative men. The bivariate logistic regression model results show that genital tract pathologies are unrelated to SCH infection: no significant difference was observed between SCH-negative and SCH-positive men.

Table 4 Prevalence of genital tract pathologies in Schistosoma haematobium- or Schistosoma mansoni-positive men of Tibati and Wouldé


In schistosomiasis endemic areas, people are infected during their routine activities when exposed to contaminated water. In this study, approximately half of the population was exposed to schistosomiasis transmission sites due to their agricultural and fishing activities. Three-quarters of the study population in Wouldé was made up of farmers working in marshy fields around the Wouldé River. The study population in Wouldé was then a high-risk group for schistosomiasis infection [3]. The prevalence of S. haematobium or S. mansoni infection was within the interval of 10–49%, which reflects a moderate occurrence in the study population in Tibati or Wouldé. Despite this moderate endemicity of schistosomiasis, 80% of men with S. haematobium heavy-intensity infection presented visible hematuria. It reflects the increase in egg population in the urothelium and is sometimes linked to bladder and ureteral calcification and renal failure [32].

Among other complications of urogenital schistosomiasis, male reproductive function impairment and even infertility are quite common. S. haematobium is more involved than S. mansoni [33]. The symptoms include epididymitis, haemospermia, pain during urination, prostatitis, dilatation and calcification of seminal vesicles, and testicular inflammation [7, 34, 35]. In the current study, the mean testicular circumference of S. mansoni-positive men was significantly higher than that of S. haematobium-positive men. The increased size of the testes could presumably be the consequence of numerous eggs trapped in that organ or/and the inflammation induced by their presence in the testes. The presence of S. haematobium or S. mansoni ova in the testes has effectively been reported in men living in SCH-endemic areas or tourists who have visited these areas [14, 19, 21,22,23, 36]. Schistosoma ova trapped in the testes directly damages the testicular tissue through inflammation and granuloma formation [37], thus impairing testicular steroidogenesis. The testis is an exocrine and endocrine gland that synthesizes and produces testosterone through steroidogenesis in Leydig cells and sperm through spermatogenesis in the seminiferous tubules [38]. When Schistosoma eggs invade the testes, inflammatory cells migrate around eggs and generate granulomatous lesions. Lenzi et al. [39] described the bilharzial granuloma as a structure composed of macrophages, lymphocytes, eosinophils, neutrophils, giant cells, and fibroblasts surrounding schistosome eggs. The modulation of Leydig cell steroidogenesis by macrophages has been demonstrated [40,41,42]. Under normal physiological and noninflammatory conditions, testicular interstitial macrophages play an essential role in Leydig cell proliferation and differentiation and stimulate steroidogenic function [40, 41]. When macrophages are activated, they produce inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-1 (IL-1) that inhibit Leydig cell steroidogenesis and thus testosterone production. They also act as transcriptional repressors of steroidogenic enzyme gene expression [40, 43]. In fact, the exposure of TM3 Leydig cells to the inflammatory cytokines TNF-α, IL-1β, and IL-6 resulted in a decrease in Leydig cell viability and testosterone concentrations [42]. Moreover, the endocrine function of the testis is perturbed by the reactive oxygen species (ROS) generated by macrophages. They impair Leydig cell mitochondria by inhibiting steroidogenic acute regulatory (StAR) protein expression [40]. The significant decrease in testosterone concentration recorded during the current study in S. haematobium-positive men and S. mansoni-positive men could be linked to the inhibition of Leydig cell steroidogenesis by secretory products of granuloma inflammatory cells. In addition, a significant correlation between S. haematobium or S. mansoni infection and reduced testosterone levels was established in our study. Hormonal imbalance in SCH-infected individuals is less reported. Authors have recorded decreased levels of hydroxyprogesterone, testosterone, and dihydrotestosterone in boys and men presenting hepatosplenic schistosomiasis [26,27,28,29]. This was associated with an increased concentration of estradiol, estrone, and estriol [25, 29], suggesting an intense aromatization of androgens to estrogens in SCH-infected persons. Such sex steroid imbalance has delayed puberty in young boys and induced hypogonadism in men [27, 29].

Authors have described hydrocele, testicular atrophy, and nodular scrotum in patients presenting testicular schistosomiasis [21]. Therefore, this study denoted genital tract pathologies in SCH-positive men such as scrotal abnormalities, nodular epididymis, varicocele, hydrocele, and inguinal hernia. Since the prevalence of these pathologies was statistically comparable between SCH-positive and SCH-negative men, it would have become a challenge to establish a correlation between schistosomiasis or reduced testosterone levels and these pathologies. However, the testosterone level of SCH-negative men in this study was similar to that of a control group of men of reproductive age involved in a survey on the effect of agropesticides on the male reproductive function of farmers in a village in the West region of Cameroon [44].

The consequence of testosterone depletion in SCH-positive men in Tibati and Wouldé would be poor semen quality since spermatogenesis relies on the ability of Leydig cells to produce testosterone [38]. Unfortunately, due to traditional and cultural beliefs, it was impossible to conduct semen analysis in this study; the population of our study areas considered masturbation (method of sperm collection) as taboo. However, some authors have reported Schistosoma egg excretion in the semen, low volume of ejaculate, decreased sperm viability, oligoasthenoteratozoospermia, azoospermia, and sperm apoptosis [15,16,17,18, 20, 36, 45,46,47]. In addition, leukocytospermia, mainly eosinophilia, and secretion of inflammatory cytokines in the semen were also reported in SCH-positive men [15, 17, 20, 36, 45]. Therefore, a clinical scheme presenting a low testosterone level and/or poor semen quality could presumably be conducted for subfertility or infertility.


This study demonstrated that S. haematobium and S. mansoni infections are associated with reducing the male reproductive hormone testosterone of men of reproductive age living in schistosomiasis endemic areas in Cameroon. The recommendations from this study are that the National Control Programme for Schistosomiasis and Intestinal Helminthiasis in Cameroon should accelerate the extension of schistosomiasis treatment to reach all individuals at risk in communities. In addition, a program of sensitization and surveillance of young people and adults suffering from male genital schistosomiasis should be set up in endemic areas.

Availability of data and materials

The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.



Disability-adjusted life years


Female genital schistosomiasis


Male genital schistosomiasis


Alanine aminotransferase


Aspartate aminotransferase


Enzyme-linked immunosorbent assay


Horseradish peroxidase


Hydrochloric acid


Analysis of variance


World Health Organization




Negative to Schistosoma infection


Positive to Schistosoma infection


Schistosomiasis transmission sites


Tumor necrosis factor-alpha





TM3 Leydig cells:

Leydig cell lines derived from 11 to 13 days mouse testes


Reactive oxygen species


Steroidogenic acute regulatory


  1. World Health Organization. Schistosomiasis [Internet]. 2020.

  2. World Health Organization. Progress report 2001–2011 and strategic plan 2012–2020. 2013.

  3. Tchuem Tchuente L-A. National Programme for the Control of Schistosomiasis and Intestinal Helminthiasis 2003 - 2019 Progress report Cameroon. 2020.

  4. World Health Organization. Preventive chemotherapy in human helminthiasis. 2006.

  5. Tchuenté LT, Rollinson D, Stothard JR, Molyneux D. Moving from control to elimination of schistosomiasis in sub-Saharan Africa: time to change and adapt strategies. Infect Dis Poverty. 2017;6:1–14.

    Article  Google Scholar 

  6. Kjetland EF, Leutscher PDC, Ndhlovu PD. A review of female genital schistosomiasis. Trends Parasitol. 2012;28:58–65.

    Article  Google Scholar 

  7. Kayuni S, Lampiao F, Makaula P, Juziwelo L, Lacourse EJ, Reinhard-Rupp J, et al. A systematic review with epidemiological update of male genital schistosomiasis (MGS): a call for integrated case management across the health system in sub-Saharan Africa. Parasite Epidemiol Control. 2018;3:e00077.

    Google Scholar 

  8. Sturt AS, Webb EL, Francis SC, Hayes RJ, Bustinduy AL. Beyond the barrier: female genital schistosomiasis as a potential risk factor for HIV-1 acquisition. Acta Trop. 2020;209:105524.

    CAS  Article  Google Scholar 

  9. Catteau X, Fakhri A, Albert V, Doukoure B, Noël J-C. Genital schistosomiasis in European women. ISRN Obstet Gynecol. 2011;2011:1–4.

    Article  Google Scholar 

  10. World Health Organization. Female genital schistosomiasis: a pocket atlas for clinical health-care professionals. Geneva: World Health Organization; 2015.

    Google Scholar 

  11. Helling-Giese G, Kjetland EF, Gundersen SG, Poggensee G, Richter J, Krantz I, et al. Schistosomiasis in women: manifestations in the upper reproductive tract. Acta Trop. 1996;62:225–38.

    CAS  Article  Google Scholar 

  12. Kjetland EF, Ndhlovu PD, Gomo E, Mduluza T, Midzi N, Gwanzura L, et al. Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS. 2006;20:593–600.

    Article  Google Scholar 

  13. Stecher CW, Kallestrup P, Kjetland EF, Vennervald B, Petersen E. Considering treatment of male genital schistosomiasis as a tool for future HIV prevention: a systematic review. Int J Public Health. 2015;60:839–48.

    Article  Google Scholar 

  14. Lopes RI, Leite KR, Prando D, Lopes RN. Testicular schistosomiasis caused by Schistosoma mansoni: a case report from Brazil. Braz J Infect Dis. 2007;11:523–4.

    Article  Google Scholar 

  15. Pérignon A, Pelicot M, Consigny PH. Genital schistosomiasis in a traveler coming back from Mali. J Travel Med. 2007;14:197–9.

    Article  Google Scholar 

  16. Chohan KR, Kling CA, Byler TK. Schistosoma haematobium ova in human semen: a case report. Fertil Steril Rep. 2020;13:1–3.

    Google Scholar 

  17. van Delft F, Visser L, Polderman A, van Lieshout L. Cough and alterations in semen after a tropical swim. Neth J Med. 2007;65:304–6.

    PubMed  Google Scholar 

  18. Al-Qahtani SM, Droupy SJ. Testicular schistosomiasis. Saudi Med J. 2010;31:325–7.

    Article  Google Scholar 

  19. Mutengo M, Mudenda V, Mwansa J, Kaonga K, Sianongo S, Wamulume H, et al. Presence of schistosomiasis in genital biopsies from patients at the University Teaching Hospital in Lusaka, Zambia. Med J Zambia. 2010;36:114–8.

    Article  Google Scholar 

  20. Tayrab E, Ashmarg AK, Shareef H, Bedawi SB, Aradaib IE. Association of Schistosoma mansoni with infertility in a Sudanese patient from schistosomiasis area of endemicity: a case report. Res J Med Sci. 2010;4:125–7.

    Article  Google Scholar 

  21. Rambau PF, Chandika A, Chalya PL, Jackson K. Scrotal swelling and testicular atrophy due to schistosomiasis in a 9-year-old boy: a case report. Case Rep Infect Dis. 2011;2011:1–3.

    Google Scholar 

  22. Adisa J, Egbujo EM, Yahaya BA, Echejoh G. Primary infertility associated with Schistosoma mansoni: a case report from the Jos Plateau, north-central Nigeria. Afr Health Sci. 2012;12:563–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Ondo CZ, Sarr A, Sow Y, Thiam I, Fall B, Sow D, et al. Bilharziome testiculaire à Schistosomia haematobium : à propos de deux observations. Progrès en Urol. 2014;24:67–9.

    Article  Google Scholar 

  24. Ekenze SO, Modekwe VO, Nzegwu MA, Ekpemo SC, Ezomike UO. Testicular schistosomiasis mimicking malignancy in a child: a case report. J Trop Pediatr. 2015;61:304–9.

    Article  Google Scholar 

  25. Rizk A, Kader MA, Hashmat H, El Agouz W, Abdalla M. Sex steroids in bilharzial liver affection. 1. Estrogens. Acta Biol Med Ger. 1980;39:991–3.

    CAS  PubMed  Google Scholar 

  26. Heshmat H, Rizk A, Abdel Kader M, Abdalla M. Sex steroids in bilharzial liver infections. Radioimmunoassay Relat Proced Med 1982. Vienna: International Atomic Energy Agency; 1982. p. 847.

  27. Cavaliere H, Leite Z, Medeiros-Neto G. Serum immunoreactive somatomedin-C levels in growth failure and delayed puberty associated with chronic hepatosplenic schistosomiasis. Clin Endocrinol (Oxf). 1986;24:617–26.

    CAS  Article  Google Scholar 

  28. El-Ridi AM, Aboul-Magd LA, Edris A, Rashed SM, Hamadto HA, Abdalla KF. Serum testosterone level variation in bilharzial male patients. J Egypt Soc Parasitol. 1987;17:87–92.

    CAS  PubMed  Google Scholar 

  29. Saad AH, Abdelbaky A, Osman AM, Abdallah KF, Salem D. Possible role of Schistosoma mansoni infection in male hypogonadism. J Egypt Soc Parasitol. 1999;29:307–23.

    CAS  PubMed  Google Scholar 

  30. United Nations, Department of Economic and Social Affairs, Population Division. 2019. World population prospects 2019, Online Edition. Rev. 1.

  31. WHO. Prevention and control of schistosomiasis and STH. WHO Technical Report. 2002. p. 912: 1–57.

  32. Regis L, Lozano F, Lopez-Pacios AM, Morote J. Urogenital schistosomiasis: a diagnosis to consider in patients with hematuria in Europe. UroToday Int J. 2013;6:1.

    Google Scholar 

  33. Ribeiro AR, Luis C, Fernandes R, Botelho MC. Schistosomiasis and infertility: what do we know? Trends Parasitol. 2019;35:964–71.

    Article  Google Scholar 

  34. Vilana R, Corachán M, Gascón J, Valls E, Bru C. Schistosomiasis of the male genital tract: transrectal sonographic findings. J Urol. 1997;158:1491–3.

    CAS  Article  Google Scholar 

  35. Shebel HM, Elsayes KM, Abou El Atta HM, Elguindy YM, El-Diasty TA. Genitourinary schistosomiasis: Life cycle and radiologic-pathologic findings. Radiographics. 2012;32:1031–46.

    Article  Google Scholar 

  36. Hassan A, El-Mogy S, Zalata K, Mostafa T. Testicular schistosomiasis: a case study. Fertil Steril. 2011;95:2124.e1-2124.e4.

    Article  Google Scholar 

  37. Abdel-Naser MB, Altenburg A, Zouboulis CC, Wollina U. Schistosomiasis (bilharziasis) and male infertility. Andrologia. 2019;51:1–6.

    Article  Google Scholar 

  38. O’Donnell L, Stanton P, Dekretser DM. Endocrinology of the male reproductive system and spermatogenesis. In: Feingold K, Anawalt B, Boyce A, editors. Endotext. South Dartmouth: Inc.; 2017.

    Google Scholar 

  39. Lenzi HL, Kimmel E, Schechtman H, Pelajo-Machado M, Romanha WS, Pacheco RG, et al. Histoarchitecture of schistosomal granuloma development and involution: morphogenetic and biomechanical approaches. Mem Inst Oswaldo Cruz. 1998;93:141–51.

    Article  Google Scholar 

  40. Hales DB. Testicular macrophage modulation of Leydig cell steroidogenesis. J Reprod Immunol. 2002;57:3–18.

    CAS  Article  Google Scholar 

  41. Hutson JC. Physiologic interactions between macrophages and Leydig cells. Exp Biol Med. 2006;231:1–7.

    CAS  Article  Google Scholar 

  42. Leisegang K, Henkel R. The in vitro modulation of steroidogenesis by inflammatory cytokines and insulin in TM3 Leydig cells. Reprod Biol Endocrinol. 2018;16:1–11.

    Article  Google Scholar 

  43. Hales DB, Diemer T, Hales KH. Role of cytokines in testicular function. Endocrine. 1999;10:201–17.

    CAS  Article  Google Scholar 

  44. Manfo FPT, Moundipa PF, Déchaud H, Tchana AN, Nantia EA, Zabot MT, et al. Effect of agropesticides use on male reproductive function: a study on farmers in Djutitsa (Cameroon). Environ Toxicol. 2012;27:423–32.

    CAS  Article  Google Scholar 

  45. Leutscher PDC, Pedersen M, Raharisolo C, Jensen JS, Hoffmann S, Lisse I, et al. Increased prevalence of leukocytes and elevated cytokine levels in semen from Schistosoma haematobium-infected individuals. J Infect Dis. 2005;191:1639–47.

    CAS  Article  Google Scholar 

  46. Kini S, Dayoub N, Raja A, Pickering S, Thong J. Schistosomiasis-induced male infertility. BMJ Case Rep. 2009;2009:bcr0120091481.

    Google Scholar 

  47. Leutscher PDC, Høst E, Reimert CM. Semen quality in Schistosoma haematobium infected men in Madagascar. Acta Trop. 2009;109:41–4.

    Article  Google Scholar 

Download references


The authors are grateful to Mr. Jean Marie Kagho, the medical practitioner who conducted medical examinations of the participants, and to Mr. Alex Christian Nguepkap Lemegne, who drew the study area map (Tibati and Wouldé).


Financial support was provided by the “Société d’Andrologie de Langue Française” (SALF) for biochemical assays. The funding body was not involved in the study design, the collection, analysis, and interpretation of data, nor writing the manuscript.

Author information

Authors and Affiliations



HBJ, LATT, and PK conceived and designed this study. HBJ and RIKN conducted the field study. HBJ, UMF, and CND computerized the raw data from the surveys and performed statistical analysis with BNF. HBJ performed biochemical assays and wrote the first draft of the manuscript with UMF. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Hermine Boukeng Jatsa.

Ethics declarations

Ethics approval and consent to participate

The protocol of the current study was approved by the National Ethics Committee of Cameroon (No. 072/CNE/DNM/08). All participants signed informed consent, and written informed consent was obtained from a parent or guardian for participants under 16 years old.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Jatsa, H.B., Femoe, U.M., Dongmo, C.N. et al. Reduction of testosterone levels in Schistosoma haematobium- or Schistosoma mansoni-infected men: a cross-sectional study in two schistosomiasis-endemic areas of the Adamawa region of Cameroon. BMC Infect Dis 22, 230 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Male genital schistosomiasis
  • Testosterone
  • Testes
  • Schistosoma haematobium
  • Schistosoma mansoni
  • Cameroon